The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Researchers Identify Gene Mutation That Causes Rare Brain Disorder
Australian scientists have identified the gene mutation responsible for Kufs disease, a rare but fatal neurodegenerative disorder.
Adrenaline Reduces Allergic Reactions To Snakebite Anti-Venom, Study
Researchers have found that giving low-dose adrenaline reduces the risk of acute severe reactions to snakebite anti-venom.
Vietnam’s Cities And Forests Get A Boost From ADB
Vietnam is set to improve clean water access, conserve threatened forests, and ease urban gridlock, funded by a $1.38 billion financial assistance package from the Asian Development Bank.
Systemic Sclerosis A New Risk Factor For Atherosclerosis
Researchers have showed that systemic sclerosis is an independent determinant for atherosclerosis, besides typical cardiovascular risk factors such as age and hypertension.
Does Responsibility To Parents Affect Academic Performance?
Researchers have found that a declining sense of obligation to one's parents correlates with a similar decline in academic achievement.
Sanofi Forsees China To Be Its Second Biggest Market
French-drugmaker Sanofi expects China to become its second biggest market after the US within five years, according to the company's CEO, Chris Viehbacher.
Indonesia Confirms Case Of Human Death From Bird Flu
The Ministry of Health of Indonesia announced today a confirmed case of human infection with avian influenza A (H5N1) virus.
Magpies Not Only Recognize Humans, But Scold Them Too!
Seoul National University researchers have discovered that black-billed magpies on campus may not only be able to recognize human faces, but also scold the human who offends them!
Lundbeck And Takeda Initiate Phase III Study For Depression Drug
Takeda and H. Lundbeck A/S announced yesterday the initiation of a phase III clinical trial in Japan for Lu AA21004 in patients with major depressive disorder.